Novozymes A/S

Novozymes A/S Receivables

The Accounts Receivable of Novozymes A/S (NSIS B.CO) as of Oct 27, 2026 is 689.20 M EUR. In the previous year, Accounts Receivable was 505.20 M EUR — a change of 36.42% (higher).

Receivables

689.20 MEUR

YoY

36.42%

Last updated:

Accounts Receivable of Novozymes A/S is 2024 689.20 M EUR. Accounts Receivable of Novozymes A/S was 2023 505.20 M EUR. It decreases by 36.42% higher compared to the previous year.

The Novozymes A/S Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2017
2.51 B EUR
Jan 1, 2018
2.89 B EUR
Jan 1, 2019
3.11 B EUR
Jan 1, 2020
2.56 B EUR
Jan 1, 2021
400.71 M EUR
Jan 1, 2022
482.83 M EUR
Jan 1, 2023
505.20 M EUR
Jan 1, 2024
689.20 M EUR
The Novozymes A/S Receivables history
YEARReceivablesYoY
689.20 MEUR+36.42%
505.20 MEUR+4.63%
482.83 MEUR+20.49%
400.71 MEUR-84.32%
2.56 BEUR-17.77%
3.11 BEUR+7.69%
2.89 BEUR+14.99%
2.51 BEUR-3.98%
2.61 BEUR+3.90%
2.52 BEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Novozymes A/S Stock analysis

What does Novozymes A/S do? Novozymes A/S is a leading company in the field of biocatalysis and microbial solutions. It was founded in Denmark in 1925 under the name Nordisk Insulinlaboratorium. In 2000, the company was renamed Novozymes A/S and became part of the globally operating Novo Group. Novozymes' business model is to optimize the use of biocatalysts, enzymes, and microorganisms to offer sustainable solutions for various industries. Biocatalysts are biological molecules that accelerate or enable chemical reactions. The company works closely with customers in agriculture, household, food and beverage, laundry and cleaning products, animal feed, bioenergy, and biopharmaceutical industries. Novozymes' offerings include various divisions. The largest is the enzymes division, which produces enzymes for various industries. Novozymes' enzymes are used in the food and beverage industry, pulp and paper industry, and bioenergy, among others. The microbial solutions division offers various microorganisms that can be used in the production of biogas, animal feed, or odor removal. Novozymes also has a bioagriculture division that develops solutions for sustainable agriculture. This includes disease- and pest-resistant bioseeds, as well as enhanced soil and plant care. The company also has a biopharmaceutical division that focuses on producing enzymes for disease treatment. An important goal of Novozymes is to promote sustainability and environmental protection. The company advocates for the use of renewable resources and energy-efficient processes. This is also reflected in their products, which contribute to optimizing agricultural processes and reducing greenhouse gas emissions, for example. One example of a Novozymes product is NovoGro, a biofertilizer for sustainable agriculture. NovoGro enhances nutrient uptake in plants and contributes to healthy soils. Another product is an enzyme blend called Novozyme 188, which is used in beer production to improve filtration. In summary, Novozymes A/S is a company specializing in biocatalysis and microbial solutions. The company works closely with customers from various industries to offer sustainable solutions and promote environmental protection. Novozymes has different divisions and offers solutions such as enzymes and microorganisms that can be used in the food and beverage industry, pulp and paper industry, bioenergy, biopharmaceuticals, and many other areas. With its commitment to sustainability and environmental protection, Novozymes contributes to shaping a better future. Novozymes A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Novozymes A/S stock

Accounts Receivable of Novozymes A/S is 689.20 M EUR in 2024.

Accounts Receivable of Novozymes A/S changed from 505.20 M EUR to 689.20 M EUR, representing a 36.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable Novozymes A/S since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Novozymes A/S historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Novozymes A/S

All Key Metrics — Novozymes A/S